Skip to Main Content

WASHINGTON — Sen. Chuck Grassley on Monday accused Democrats of walking away from negotiations on a bill meant to lower prescription drug prices — a bill that has, until now, enjoyed more support from Democrats in the Senate than from most Republicans in the chamber.

The Iowa Republican’s surprisingly public airing of grievances, in a Wall Street Journal op-ed, is the latest indication that Congress is unlikely to pass meaningful pharmaceutical industry reforms before November’s election.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.